Latest Articles
Ascentage Pharma Presents Promising Cancer Research at AACR - The Clinical Trial Vanguard
Ascentage Pharma Presents Promising Cancer Research at AACR The Clinical Trial Vanguard
Published: April 20, 2026, 8 a.m.
This inflammatory condition is almost as common as endometriosis, but is rarely spoken about - Vogue Australia
This inflammatory condition is almost as common as endometriosis, but is rarely spoken about Vogue Australia
Published: April 20, 2026, 6:43 a.m.
I Think It’s Very Helpful” Highlights 39% GP Visits And 9-Year Wait In 2026 - Glass Almanac
I Think It’s Very Helpful” Highlights 39% GP Visits And 9-Year Wait In 2026 Glass Almanac
Published: April 20, 2026, 4:04 a.m.
Lego’s May the 4th Star Wars drop is here, and half the sets are under $50 - Mashable
Lego’s May the 4th Star Wars drop is here, and half the sets are under $50 Mashable
Published: April 20, 2026, 1:52 a.m.
Trans woman Steph Richards steps down from women’s health charity Endometriosis South Coast role after criticism from MPs including Suella Braverman - MSN
Trans woman Steph Richards steps down from women’s health charity Endometriosis South Coast role after criticism from MPs including Suella Braverman MSN
Published: April 19, 2026, 10:20 p.m.
Marisa And The Moths release new music video for ‘Nothing’s Getting Better’ - Distorted Sound Magazine -
Marisa And The Moths release new music video for ‘Nothing’s Getting Better’ Distorted Sound Magazine -
Published: April 19, 2026, 7:45 p.m.
Where U.S. science has been hit hardest after Trump’s first year - The Washington Post
Where U.S. science has been hit hardest after Trump’s first year The Washington Post
Published: April 19, 2026, 5 p.m.
For U.S. medical researchers, shrinking labs and bare budgets are the new reality - The Washington Post
For U.S. medical researchers, shrinking labs and bare budgets are the new reality The Washington Post
Published: April 19, 2026, 2:31 p.m.
The menu that promises to make life easier for many women - The Jerusalem Post
The menu that promises to make life easier for many women The Jerusalem Post
Published: April 19, 2026, 11 a.m.
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer Oncodaily
Published: April 18, 2026, 6:23 p.m.
Link copied to clipboard!